Evidence map›Paper›PMID 32150871›Full record

ReviewInternational journal of molecular sciences2020

The Complex Network between MYC Oncogene and microRNAs in Gastric Cancer: An Overview.

Ana Carolina Anauate, Mariana Ferreira Leal, Danielle Queiroz Calcagno, Carolina Oliveira Gigek, Bruno Takao Real Karia, Fernanda Wisnieski, Leonardo Caires Dos Santos, Elizabeth Suchi Chen, Rommel Rodríguez Burbano, Marília Arruda Cardoso Smith

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ana Carolina AnauateDisciplina de Genética, Departamento de Morfologia e Genética, Universidade Federal de São Paulo, São Paulo SP 04023-062, Brazil.ORCID 0000-0001-6158-3412
Mariana Ferreira LealDisciplina de Genética, Departamento de Morfologia e Genética, Universidade Federal de São Paulo, São Paulo SP 04023-062, Brazil.
Danielle Queiroz CalcagnoNúcleo de Pesquisas em Oncologia, Hospital Universitário João de Barros Barreto, Universidade Federal do Pará, Belém PA 66075-110, Brazil.
Carolina Oliveira GigekDisciplina de Genética, Departamento de Morfologia e Genética, Universidade Federal de São Paulo, São Paulo SP 04023-062, Brazil.
Bruno Takao Real KariaDisciplina de Genética, Departamento de Morfologia e Genética, Universidade Federal de São Paulo, São Paulo SP 04023-062, Brazil.
Fernanda WisnieskiDisciplina de Genética, Departamento de Morfologia e Genética, Universidade Federal de São Paulo, São Paulo SP 04023-062, Brazil.
Leonardo Caires Dos SantosDisciplina de Genética, Departamento de Morfologia e Genética, Universidade Federal de São Paulo, São Paulo SP 04023-062, Brazil.
Elizabeth Suchi ChenDisciplina de Genética, Departamento de Morfologia e Genética, Universidade Federal de São Paulo, São Paulo SP 04023-062, Brazil.ORCID 0000-0002-3573-0164
Rommel Rodríguez BurbanoNúcleo de Pesquisas em Oncologia, Hospital Universitário João de Barros Barreto, Universidade Federal do Pará, Belém PA 66075-110, Brazil.
Marília Arruda Cardoso SmithDisciplina de Genética, Departamento de Morfologia e Genética, Universidade Federal de São Paulo, São Paulo SP 04023-062, Brazil.
Universidade Federal de São Paulo · BRUniversidade Federal do Pará · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 303871/2014-8Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 201567/2009-1Fundação de Amparo à Pesquisa do Estado de São Paulo 2012/14768-5Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/19953-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2016/25562-0
6 · The paper itself

Abstract

Despite the advancements in cancer treatments, gastric cancer is still one of the leading causes of death worldwide. In this context, it is of great interest to discover new and more effective ways of treating this disease. Accumulated evidences have demonstrated the amplification of 8q24.21 region in gastric tumors. Furthermore, this is the region where the widely known

Indexed as

Gene Expression Regulation, NeoplasticAnimalsHumansMicroRNAsProto-Oncogene Proteins c-mycStomach NeoplasmsMicroRNAsProto-Oncogene Proteins c-myc8q24.21gastric cancermicroRNAMYCtarget therapy

Identifiers

PMID32150871
PMCPMC7084225
OpenAlexW3009998385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.